Share this post on:

Product Name :
Etrasimod arginine

Search keywords :
Etrasimod

drugId :
null

Target Vo:
Sphingosine 1-Phosphate Receptor 1

Target Vo Short Name :
S1PR1

Moa_Name:
Sphingosine 1-Phosphate Receptor 1 modulators

First Approval Country :
United States

First Approval Date Filter:
2023

Origin Company_Name :
Arena Pharmaceuticals Inc

Active Company_Name :
Arena Pharmaceuticals Inc

Active Indication_Name:
Colitis, Ulcerative

In Active Indication_Name:
Pyoderma Gangrenosum

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD9 Rabbit mAb supplier
Rovalpituzumab Protocol
Osteocalcin Antibody: Osteocalcin Antibody is an unconjugated, approximately 11 kDa, rabbit-derived, anti-Osteocalcin polyclonal antibody. Osteocalcin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.

Share this post on:

Author: Interleukin Related